3E0B728 ICD-10-PCS Code: Introduction of Oxazolidinones into Ear, Via Natural or Artificial Opening

Related Codes

Same operation — other Body System / Region

Same table and root operation, differing only in the body system / region character.

3E09728 — Introduction of Oxazolidinones into Nose, Via Natural or Artificial Opening, 3E0C728 — Introduction of Oxazolidinones into Eye, Via Natural or Artificial Opening, 3E0D728 — Introduction of Oxazolidinones into Mouth and Pharynx, Via Natural or Artificial Opening, 3E0E728 — Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening, 3E0F728 — Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening, 3E0G728 — Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening, 3E0H728 — Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening, 3E0J728 — Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening, +3 more

Same operation — other Approach

Same table and root operation, differing only in the approach character.

3E0B328 — Introduction of Oxazolidinones into Ear, Percutaneous Approach, 3E0BX28 — Introduction of Oxazolidinones into Ear, External Approach

Same operation — other Qualifier

Same table and root operation, differing only in the qualifier character.

3E0B729 — Introduction of Other Anti-infective into Ear, Via Natural or Artificial Opening

Same procedure category (CCSR), other tables

AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration of antibiotics (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.

XW0334A — Introduction of Cefepime-taniborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW0335A — Introduction of Ceftobiprole Medocaril Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW03396 — Introduction of Ceftolozane/Tazobactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6, XW033K9 — Introduction of Sulbactam-Durlobactam into Peripheral Vein, Percutaneous Approach, New Technology Group 9, XW033PB — Introduction of Aztreonam-avibactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 11, XW033WB — Introduction of Fosfomycin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 11, XW0434A — Introduction of Cefepime-taniborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10, XW0435A — Introduction of Ceftobiprole Medocaril Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10, XW04396 — Introduction of Ceftolozane/Tazobactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6, XW043K9 — Introduction of Sulbactam-Durlobactam into Central Vein, Percutaneous Approach, New Technology Group 9, XW043PB — Introduction of Aztreonam-avibactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 11, XW043WB — Introduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 11, XW0DX38 — Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8, XW0G738 — Introduction of Maribavir Anti-infective into Upper GI, Via Natural or Artificial Opening, New Technology Group 8, XW0H738 — Introduction of Maribavir Anti-infective into Lower GI, Via Natural or Artificial Opening, New Technology Group 8, XW0U0GA — Introduction of Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System into Joints, Open Approach, New Technology Group 10, XW0V0P7 — Introduction of Gentamicin-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7

Contextual Map

Every relationship of 3E0B728 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

• 3E0[PCS table]— CMS ICD-10-PCS tables
• Administration — Section: Administration[Section]: “Administration”— CMS ICD-10-PCS tables
• Physiological Systems and Anatomical Regions — Body System: Physiological Systems and Anatomical Regions[Body System]: “Physiological Systems and Anatomical Regions”— CMS ICD-10-PCS tables
• Introduction — Operation: Introduction[Operation]: “Introduction”— CMS ICD-10-PCS tables

Clinical classification (CCSR)

• ADM015 — Administration of antibiotics[CCSR category]: “Administration of antibiotics — Administration of Therapeutic Substances”— AHRQ CCSR for ICD-10-PCS Procedures (HCUP) · v2026.1

Nearest codes

• 3E09728 — Introduction of Oxazolidinones into Nose, Via Natural or Artificial Opening[One axis away]— CMS ICD-10-PCS tables
• 3E0B328 — Introduction of Oxazolidinones into Ear, Percutaneous Approach[One axis away]— CMS ICD-10-PCS tables
• 3E0B729 — Introduction of Other Anti-infective into Ear, Via Natural or Artificial Opening[One axis away]— CMS ICD-10-PCS tables
• 3E0BX28 — Introduction of Oxazolidinones into Ear, External Approach[One axis away]— CMS ICD-10-PCS tables
• 3E0C728 — Introduction of Oxazolidinones into Eye, Via Natural or Artificial Opening[One axis away]— CMS ICD-10-PCS tables
• 3E0D728 — Introduction of Oxazolidinones into Mouth and Pharynx, Via Natural or Artificial Opening[One axis away]— CMS ICD-10-PCS tables
• 3E0E728 — Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening[One axis away]— CMS ICD-10-PCS tables
• 3E0F728 — Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening[One axis away]— CMS ICD-10-PCS tables